Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density

Sundeep Khosla, Shreyasee Amin, Ravinder Jit Singh, E. J. Atkinson, L. J. Melton, B. L. Riggs

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Summary: In men, measurement of serum testosterone and estradiol levels with immunoassays correlated with mass spectroscopic measurements, and correlations of sex steroids with volumetric bone mineral density were similar. Introduction: While immunoassays have been used extensively for measurement of serum testosterone (T) and estradiol (E2) levels, there is concern about their specificity, particularly at low E2 levels as present in men. Methods: We compared T and E2 measured by mass spectroscopy to levels measured by immunoassay in men (n=313, age 22 to 91 years) and related these to volumetric bone mineral density (vBMD) at various skeletal sites. Results: Serum T and non-SHBG bound (or bioavailable) T levels by immunoassay correlated well with the corresponding mass spectroscopy measurements (R=0.90 and 0.95, respectively, P<0.001); the correlations for serum E2 measured using the two techniques were less robust (R=0.63 for total E 2 and 0.84 for bioavailable E2, P<0.001). Overall relationships between serum bioavailable T and E2 levels with vBMD at various skeletal sites were similar for the immunoassay and mass spectroscopic measures. Conclusions: Although E2 levels with immunoassay correlate less well with the mass spectroscopic measurements than do the T measurements in men, our findings indicate that the fundamental relationships observed previously between vBMD and the sex steroids by immunoassay are also present with the mass spectroscopic measurements.

Original languageEnglish (US)
Pages (from-to)1465-1471
Number of pages7
JournalOsteoporosis International
Volume19
Issue number10
DOIs
StatePublished - Oct 2008

Fingerprint

Immunoassay
Bone Density
Mass Spectrometry
Steroids
Serum
Testosterone
Estradiol
Cancellous Bone

Keywords

  • Assays
  • Bone
  • Osteoporosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{269fd8088f5d40aa81f7f2242a90d54d,
title = "Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density",
abstract = "Summary: In men, measurement of serum testosterone and estradiol levels with immunoassays correlated with mass spectroscopic measurements, and correlations of sex steroids with volumetric bone mineral density were similar. Introduction: While immunoassays have been used extensively for measurement of serum testosterone (T) and estradiol (E2) levels, there is concern about their specificity, particularly at low E2 levels as present in men. Methods: We compared T and E2 measured by mass spectroscopy to levels measured by immunoassay in men (n=313, age 22 to 91 years) and related these to volumetric bone mineral density (vBMD) at various skeletal sites. Results: Serum T and non-SHBG bound (or bioavailable) T levels by immunoassay correlated well with the corresponding mass spectroscopy measurements (R=0.90 and 0.95, respectively, P<0.001); the correlations for serum E2 measured using the two techniques were less robust (R=0.63 for total E 2 and 0.84 for bioavailable E2, P<0.001). Overall relationships between serum bioavailable T and E2 levels with vBMD at various skeletal sites were similar for the immunoassay and mass spectroscopic measures. Conclusions: Although E2 levels with immunoassay correlate less well with the mass spectroscopic measurements than do the T measurements in men, our findings indicate that the fundamental relationships observed previously between vBMD and the sex steroids by immunoassay are also present with the mass spectroscopic measurements.",
keywords = "Assays, Bone, Osteoporosis",
author = "Sundeep Khosla and Shreyasee Amin and Singh, {Ravinder Jit} and Atkinson, {E. J.} and Melton, {L. J.} and Riggs, {B. L.}",
year = "2008",
month = "10",
doi = "10.1007/s00198-008-0591-5",
language = "English (US)",
volume = "19",
pages = "1465--1471",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "10",

}

TY - JOUR

T1 - Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density

AU - Khosla, Sundeep

AU - Amin, Shreyasee

AU - Singh, Ravinder Jit

AU - Atkinson, E. J.

AU - Melton, L. J.

AU - Riggs, B. L.

PY - 2008/10

Y1 - 2008/10

N2 - Summary: In men, measurement of serum testosterone and estradiol levels with immunoassays correlated with mass spectroscopic measurements, and correlations of sex steroids with volumetric bone mineral density were similar. Introduction: While immunoassays have been used extensively for measurement of serum testosterone (T) and estradiol (E2) levels, there is concern about their specificity, particularly at low E2 levels as present in men. Methods: We compared T and E2 measured by mass spectroscopy to levels measured by immunoassay in men (n=313, age 22 to 91 years) and related these to volumetric bone mineral density (vBMD) at various skeletal sites. Results: Serum T and non-SHBG bound (or bioavailable) T levels by immunoassay correlated well with the corresponding mass spectroscopy measurements (R=0.90 and 0.95, respectively, P<0.001); the correlations for serum E2 measured using the two techniques were less robust (R=0.63 for total E 2 and 0.84 for bioavailable E2, P<0.001). Overall relationships between serum bioavailable T and E2 levels with vBMD at various skeletal sites were similar for the immunoassay and mass spectroscopic measures. Conclusions: Although E2 levels with immunoassay correlate less well with the mass spectroscopic measurements than do the T measurements in men, our findings indicate that the fundamental relationships observed previously between vBMD and the sex steroids by immunoassay are also present with the mass spectroscopic measurements.

AB - Summary: In men, measurement of serum testosterone and estradiol levels with immunoassays correlated with mass spectroscopic measurements, and correlations of sex steroids with volumetric bone mineral density were similar. Introduction: While immunoassays have been used extensively for measurement of serum testosterone (T) and estradiol (E2) levels, there is concern about their specificity, particularly at low E2 levels as present in men. Methods: We compared T and E2 measured by mass spectroscopy to levels measured by immunoassay in men (n=313, age 22 to 91 years) and related these to volumetric bone mineral density (vBMD) at various skeletal sites. Results: Serum T and non-SHBG bound (or bioavailable) T levels by immunoassay correlated well with the corresponding mass spectroscopy measurements (R=0.90 and 0.95, respectively, P<0.001); the correlations for serum E2 measured using the two techniques were less robust (R=0.63 for total E 2 and 0.84 for bioavailable E2, P<0.001). Overall relationships between serum bioavailable T and E2 levels with vBMD at various skeletal sites were similar for the immunoassay and mass spectroscopic measures. Conclusions: Although E2 levels with immunoassay correlate less well with the mass spectroscopic measurements than do the T measurements in men, our findings indicate that the fundamental relationships observed previously between vBMD and the sex steroids by immunoassay are also present with the mass spectroscopic measurements.

KW - Assays

KW - Bone

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=51249086623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51249086623&partnerID=8YFLogxK

U2 - 10.1007/s00198-008-0591-5

DO - 10.1007/s00198-008-0591-5

M3 - Article

C2 - 18338096

AN - SCOPUS:51249086623

VL - 19

SP - 1465

EP - 1471

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 10

ER -